The Sleep Society

https://www.planetary.org/planetary-radio/2025-sleep-in-space

The science of sleep in space Erin Flynn-Evans, director of the Fatigue Countermeasures Laboratory at NASA Ames Research Center, shares how sleep science is helping astronauts stay…

https://www.sleepdiplomat.com/

Dr. Matthew Walker | Sleep Diplomat Dr. Matthew Walker, Ph.D. — Professor of Neuroscience and Biomedical Engineering at UT Dallas. Author of Why We Sleep. Founder & CEO of Nightfall IQ VIP.

Dr Alex Sweetman Transitions to Full-Time Research

Dr Alex Sweetman has announced his transition from the Australasian Sleep Association (ASA) into a full-time research position at the University of Western Australia, where he will focus on implementing cognitive behavioural therapy for insomnia (CBT-I) into routine clinical practice.

During his four years with the ASA, primary care grant programs involving around 250 sleep medicine and primary care experts, together with professional societies, delivered evidence-based sleep education to more than 38,000 Australian primary care clinicians. Leadership of the final year of the ASA program has now passed to Associate Professor Sara Winter.

WEARABLES

The wearable healthcare devices market is expected to grow from USD 45.29 billion in 2025 to USD 75.98 billion by 2030, registering a CAGR of 10.9% during the forecast period. Wearable healthcare devices are self-contained tools worn or attached to the body to monitor physiological and metabolic changes. They track health metrics such as sleep patterns, blood glucose, and vital signs, assist in diagnosing conditions like sleep apnea, and support therapeutic applications including pain management, rehabilitation, and respiratory care. Market growth is driven by rising health awareness, preventive care, and the prevalence of chronic conditions. Advances in AI, real-time monitoring, and EHR integration have expanded wearables from fitness tracking to clinical diagnostics and therapy. Investments, smartphone adoption, improved connectivity, and wireless monitoring are supporting expansion, while AI and 5G are expected to accelerate innovation. However, regulatory gaps, data security concerns, and clinical accuracy limitations may restrain growth.
TAKEAWAYS
1. The wearable healthcare devices market is segmented into trackers, smartwatches, patches, and smart clothing. Among these, smartwatches stand out for their multifunctional role, combining traditional fitness tracking with advanced clinical features that enhance both preventive care and remote patient monitoring.
2. The wearable healthcare devices market is segmented into diagnostic & monitoring devices and therapeutic devices. Diagnostic & monitoring devices track key health indicators such as heart rate, temperature, SpO2, and blood pressure, while therapeutic devices are used in areas like pain management and respiratory support.
3. By grade, the wearable healthcare devices market is segmented into consumer-grade and clinical-grade devices. Consumer-grade devices include smartwatches, fitness trackers, wristbands, and smart clothing that are easily accessible to the public without a prescription. These devices are widely used in fitness, wellness, and lifestyle management, offering features such as heart rate monitoring, ECG, and sleep tracking.
4. By distribution channel, the wearable healthcare devices market is categorized into pharmacies, online channels, and hypermarkets. Pharmacies and hypermarkets serve immediate purchase needs, while online channels provide broader access to products such as smartwatches, fitness trackers, blood pressure monitors, and sleep monitoring devices.
5. The wearable healthcare devices market is segmented into general health & fitness, remote patient monitoring, and home healthcare. General health & fitness wearables lead in demand due to their widespread use for preventive health, wellness tracking, and lifestyle management, followed by remote patient monitoring and home healthcare, which are increasingly adopted for chronic disease management and telehealth applications.
6. The Asia Pacific market is expected to grow fastest, with a CAGR of 13.1%, driven by rising health consciousness, increasing adoption of digital health technologies, expanding telemedicine and eHealth initiatives, and growing use of consumer-grade wearables across countries like China, India, and Japan.
7. The major market players have adopted both organic and inorganic strategies, including product launches, partnerships, and acquisitions. Leading companies such as Apple Inc., Samsung, Abbott, DexCom, Inc., and Fitbit Inc. have strengthened their product portfolios and expanded their global presence to meet the rising demand for wearable healthcare devices. Continuous innovation in health-tracking features, clinically validated solutions, and fitness-focused monitoring capabilities has helped these players maintain competitive advantage in a rapidly evolving market.

The wearable healthcare devices market is driven by rising health consciousness and the shift toward lifestyle and home-based healthcare. Advances in wearable sensors, AI, and data analytics are improving early diagnosis and chronic disease management. Growth is further supported by the expanding geriatric population, rising prevalence of chronic illnesses, and increased investment in digital health solutions. Widespread smartphone adoption and 3G/4G connectivity enhance device usability. However, regulatory inconsistencies, data privacy concerns, and accuracy issues pose challenges, along with limited battery life and design complexities. Opportunities exist through AI and 5G integration, as well as the growing preference for wireless connectivity in healthcare, supporting further market expansion.

TRENDS
Rising awareness about fitness is expected to drive growth in the wearable healthcare devices market during the forecast period. Technological advancements are also likely to reshape the business revenue mix in the coming years. Prioritizing user satisfaction and adapting to evolving consumer preferences are essential strategies for sustained growth in this dynamic industry. Many OEMs are currently missing opportunities to develop wearable devices specifically for chronic disease management. Collaborations with research institutions and pharmaceutical companies can enable the use of wearables for data collection and health monitoring in various studies. Companies that strategically embrace these trends and incorporate innovative features into their devices are poised to experience a significant shift in their revenue mix.

Thank to marketsandmarkets.com
Healthcare Devices Market

News from Dr. Alex Sweetman - Sleep Drive - A digital insomnia management ecosystem.

We are very excited to share some recent MRFF success that will support the transformation of insomnia management in Australia.

Over the past 4 years, Cele Richardson, Chelsea Reynolds and I have been developing and testing a suite of digital resources to improve awareness, identification, triaging and management of insomnia with Cognitive Behavioural Therapy for insomnia.

This $3M grant led by The University of Western Australia in collaboration with Nick Zwar, Bianca Cannon, Lauren McLellan, and Allan Smith will allow us to implement a digital stepped-care insomnia management ecosystem tailored for the Australian healthcare system, and support new collaborative insomnia research projects throughout Australia. We have started a clinical trial to provide free access to 10,000 people with insomnia.

https://www.linkedin.com/posts/sleephealth-obstructivesleepapnea-insomnia-share-7482799236292489216-stVD/?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAFxQ6wUBbizyJ7vxqI_JrYJ15-yGPrYKlFE

Diagnosing COMISA: Insomnia and Sleep Apnea Overlap | Sleep Institute: Clinical Insights by Resmed posted on the topic | LinkedIn A patient diagnosed with obstructive sleep apnea (OSA) may still have insomnia that requires separate clinical attention. A patient presenting with chronic insomnia may have undetected OSA. Comorbid insomnia and sleep apnea (COMISA) sits in this diagnostic overlap, where shared symptoms such as freq...

Come on Canada 🇨🇦